IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.06% | 15.62% | 22.38% | 19.33% | 18.61% |
| Total Depreciation and Amortization | 12.73% | 11.92% | 10.97% | 11.73% | 11.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.70% | 211.02% | 329.56% | 360.60% | 2,279.19% |
| Change in Net Operating Assets | 79.42% | 48.51% | -128.05% | -70.76% | -206.27% |
| Cash from Operations | 30.40% | 51.41% | 24.96% | 27.21% | 18.68% |
| Capital Expenditure | 7.63% | 3.53% | -4.94% | -3.10% | -0.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 113.45% | -60.11% | -44.66% | -22.41% | -818.82% |
| Cash from Investing | -126.61% | -1.22% | -8.05% | 34.20% | 25.15% |
| Total Debt Issued | 31.22% | -42.25% | 562.59% | -- | -- |
| Total Debt Repaid | -286.90% | -82.19% | -471.18% | -471.18% | 31.08% |
| Issuance of Common Stock | 13.15% | 180.34% | 238.67% | 109.84% | 108.49% |
| Repurchase of Common Stock | 14.08% | 2.17% | -8.18% | -44.44% | -93.03% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.91% | -18.23% | 1.71% | -32.67% | -39.47% |
| Foreign Exchange rate Adjustments | -174.11% | -120.38% | 263.13% | 217.52% | -70.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.42% | 113.65% | 115.66% | 34.69% | -335.69% |